A Coronary Artery Calcium Score of Zero Indicates Low Cardiovascular Risk Despite Elevated LDL-Cholesterol
A calcium score of zero generally indicates low cardiovascular risk even in the presence of high cholesterol levels, with annual event rates consistently below 1% and 10-year risk typically under 5%, though important exceptions exist for younger patients and those with specific high-risk features.
The "Power of Zero" - What the Evidence Shows
A CAC score of zero confers remarkably low cardiovascular risk across multiple populations. In asymptomatic patients with CAC = 0, annual mortality rates remain below 0.5-1% for over 15 years, regardless of other traditional risk factors 1. This protective effect persists even in patients initially classified as high risk by traditional risk calculators 1.
The data are compelling:
- Among 29,312 asymptomatic patients with CAC = 0, only 0.47% experienced adverse cardiovascular events over 50 months of follow-up 1
- Mortality for CAC = 0 patients remained <1% for the first 5 years even among those with Framingham risk scores >20% 1
- CAC = 0 was a stronger predictor of low risk than the absence of all traditional cardiovascular risk factors 1
High Cholesterol Populations: The Critical Nuance
Severe Hypercholesterolemia (LDL-C ≥190 mg/dL)
Even among patients with severe hypercholesterolemia, 37-45% have CAC = 0, and these individuals maintain significantly lower cardiovascular risk 2, 3. In the Multi-Ethnic Study of Atherosclerosis, patients with LDL-C ≥190 mg/dL and CAC = 0 had:
- 10-year cardiovascular risk of only 3.7% (0.4% per year)
- Adjusted hazard ratio of 0.25 compared to those with CAC >0 2
Similarly, in the CLARIFY study of 1,904 patients with severe hypercholesterolemia, those with CAC = 0 had substantially lower ASCVD event rates, with CAC ≥100 conferring a hazard ratio of 3.57 compared to CAC <100 3.
The Age-Dependent Exception: Younger Patients
The most important caveat is age—younger patients with elevated LDL-C and CAC = 0 remain at higher risk due to non-calcified plaque burden. This is the critical limitation of relying solely on CAC in younger individuals.
Recent 2025 data from the Western Denmark Heart Registry demonstrates that in symptomatic individuals with CAC = 0 4:
- Per 1 mmol/L higher LDL-C, the adjusted hazard ratio for coronary heart disease was 1.37 at age ≤45 years
- The association between elevated LDL-C and non-calcified plaque was strongest in younger patients (adjusted OR 1.39 at age ≤45 vs 1.11 at age >60)
- 11% of patients with CAC = 0 had non-calcified plaques on CT angiography
This reflects the biological reality that coronary atherosclerosis begins as non-calcified plaque, which takes decades to calcify.
Guideline-Based Recommendations for Statin Therapy
When to Withhold Statins Despite High Cholesterol
Most international guidelines agree that CAC = 0 justifies downgrading risk and withholding statin therapy in asymptomatic patients, even with elevated cholesterol 5. The ACC/AHA, Canadian Cardiovascular Society, and CSANZ guidelines all support deferring statin therapy when CAC = 0 and other ASCVD risk factors remain low 5.
Critical Exceptions - When CAC = 0 Does NOT Mean Low Risk
The Canadian guidelines specify that statin therapy should still be considered in patients with CAC = 0 if ANY of the following are present 5:
- Active cigarette smoking
- Diabetes mellitus
- Poorly controlled hypertension
- Genetic dyslipidemias (familial hypercholesterolemia)
- Elevated lipoprotein(a)
- Strong family history of premature ASCVD events
Age-Specific Considerations
For younger patients (age <45-50), the protective value of CAC = 0 is less reliable due to non-calcified plaque burden. LDL-C control remains important over a long-time horizon in younger individuals despite CAC = 0 4.
For intermediate-risk patients aged ≥55 years with CAC = 0, risk can be confidently downgraded and statin therapy deferred, with reassessment in 3-5 years 1.
Practical Clinical Algorithm
For asymptomatic patients with elevated LDL-C:
- Calculate 10-year ASCVD risk using appropriate risk calculator
- If borderline or intermediate risk (5-20%), consider CAC scoring
- If CAC = 0:
- Age ≥55 years + no high-risk features → Defer statin therapy, reassess in 3-5 years
- Age <45 years → Consider statin therapy given non-calcified plaque risk, especially if LDL-C remains significantly elevated
- Any age with high-risk features (smoking, diabetes, familial hypercholesterolemia, strong family history) → Initiate statin therapy despite CAC = 0
- If CAC 1-99: Shared decision-making, favor statin therapy if age ≥55
- If CAC ≥100: Initiate statin therapy regardless of age
Common Pitfalls to Avoid
Do not assume CAC = 0 means no atherosclerosis exists—it only means no calcified atherosclerosis. Approximately 11% of patients with CAC = 0 have non-calcified plaques 4.
Do not use CAC = 0 as justification to defer statins in younger patients (<45 years) with severe hypercholesterolemia or genetic dyslipidemias—these patients accumulate non-calcified plaque burden that won't be detected by CAC scoring 4.
Do not forget that the "warranty period" of CAC = 0 varies by age and risk factors—younger patients and those with diabetes or other risk factors require more frequent reassessment (3-5 years) 1.
The European Society of Cardiology guidelines notably differ by not explicitly recommending risk downgrading with CAC = 0, reflecting a more conservative European approach 5.